Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-152
Closed -$32K – 2816
2023
Q4
$32K Buy
152
+15
+11% +$3.22K ﹤0.01% 1119
2023
Q3
$26K Buy
137
+10
+8% +$2K ﹤0.01% 1092
2023
Q2
$25K Sell
127
-23
-15% -$4.57K ﹤0.01% 972
2023
Q1
$19K Buy
150
+5
+3% +$802 ﹤0.01% 1390
2022
Q4
$20K Buy
145
+31
+27% +$4K ﹤0.01% 1306
2022
Q3
$20K Buy
114
+3
+3% +$489 ﹤0.01% 1101
2022
Q2
$16K Buy
+111
New +$16K ﹤0.01% 1054

Blue Trust's SGEN Position: Q1 2024 in Review

Blue Trust sold out of Seagen (SGEN) in Q1 2024, closing a stake of 152 shares — an estimated $32K sold.

Blue Trust first reported a position in SGEN in Q2 2022 and held it in 7 quarters. The position peaked at $32K in Q4 2023. 0 funds tracked by Wall St. Rank hold SGEN as of Q1 2024.

  • Blue Trust reported no remaining Seagen position as of Q1 2024 after selling out during the quarter.
  • Blue Trust sold 152 Seagen shares in Q1 2024, an estimated $32K.
  • Blue Trust first reported a position in Seagen in Q2 2022 and held it in 7 quarters.
  • Blue Trust's Seagen position peaked at $32K in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Seagen as of Q1 2024.

Based on Blue Trust's 13F filing for Q1 2024, filed 1 May 2024.